Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators
|
|
- Lambert Griffith
- 5 years ago
- Views:
Transcription
1 See discussions, stats, and author profiles for this publication at: Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators Article in Drug and Alcohol Dependence July 1999 Impact Factor: 3.42 DOI: /S (98) Source: PubMed CITATIONS 49 READS 27 3 authors, including: Andrew Morral RAND Corporation 84 PUBLICATIONS 2,210 CITATIONS Martin Y Iguchi RAND Corporation 112 PUBLICATIONS 3,098 CITATIONS SEE PROFILE SEE PROFILE Available from: Martin Y Iguchi Retrieved on: 10 May 2016
2 Drug and Alcohol Dependence 55 (1999) Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators Andrew R. Morral a, *, Mark A. Belding b, Martin Y. Iguchi a a Drug Policy Research Center (RAND), PO Box 2138, 1700 Main Street, Santa Monica, CA , USA b Uni ersity of Pennsyl ania, Pennsyl ania, USA Received 31 July 1998; accepted 10 October 1998 Abstract Exhaustive searches have uncovered few demographic or other pretreatment factors that reliably predict performance in substance abuse treatments. In this study we evaluate whether early treatment response offers improved prediction of treatment response 6 and 9 months later. New admissions to methadone maintenance treatment (n=59) were dichotomized into outcome groups based on treatment retention and ongoing drug use as revealed by urinalysis results 6 and 9 months after admission. Regression analyses revealed two early (week 2) performance measures, counseling attendance and opiate abstinence, could be used to correctly classify the outcomes of more than 80% of the sample. Strikingly, of the 20 participants who neither submitted an opiate-negative urine sample in week 2 nor attended at least two scheduled counseling sessions by that time, not one achieved a superior 6-month outcome. The odds of having a superior outcome increased considerably for those who submitted two opiate negative urine samples and attended two counseling sessions by week 2. Thus, 6-month outcomes were well predicted by treatment performance in week 2. Similar results are reported for month 9 outcomes Elsevier Science Ireland Ltd. All rights reserved. Keywords: Substance abuse treatment; Treatment outcomes; Prognosis; Methadone maintenance therapy; Urinalyses 1. Introduction The effectiveness of methadone maintenance treatment in reducing opiate use, related crime and HIV risk behaviors is well documented (Ball and Ross, 1991; McLellan et al., 1993). Nonetheless, many patients drop out of treatment or continue using opiates and other illicit drugs (Morral et al., 1997; Nunes et al., 1997; Belding et al., 1998). Early identification of such patients could facilitate the development of intensive treatments targeted to their needs. Attempts to identify poor responders using demographic and drug-use history variables have failed to yield consistent predictors (McLellan, 1983; Hubbard et al., 1989; Morral et al., 1997). However, several studies suggest that patterns of * Corresponding author. drug abuse treatment response might become evident quite early in treatment (Alterman et al., 1997; Morral et al., 1997; Cacciola et al., 1998). Early treatment performance might therefore be useful for identifying those patients likely to respond poorly to further treatment. In this study we use measures of performance 2 weeks after admission to predict treatment response 6 and 9 months later. A recent review of clinic records at a VA methadone clinic revealed that of patients who received methadone treatment for at least 6 months, 22% used illicit opiates regularly as indicated by urinalysis results (Belding et al., 1998). Similarly, an earlier survey of patients at four methadone clinics in the Philadelphia area found that among patients who received treatment for at least 6 months, 23% reported using illicit opiates on 10 or more days in the 30 days prior to the survey (Belding et al., 1995). A total of 12% of these patients reported /99/$ - see front matter 1999 Elsevier Science Ireland Ltd. All rights reserved. PII: S (98)
3 26 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) or more days of cocaine use. When the definition of a poor or inferior treatment response at 6 months is enlarged to include clients who drop out of treatment, these rates often rise to 50 80% (see e.g. GAO, 1990) Unfortunately, few robust predictors of treatment performance have been found. Among these few, greater severity of drug use and psychiatric problems are among the most consistent predictors of poor outcomes (McLellan et al., 1983, 1994; Ball and Ross, 1991). Typically, however, these factors account for only a small fraction of outcome variance, they are not consistently found to be related to outcomes, and antithetical results are common (Saxon et al., 1994). Moreover, many studies find no strong or consistent relations between pretreatment factors and drug abuse treatment outcomes (Hubbard, et al., 1989; Stitzer et al., 1992; Saxon et al., 1994; Phillips, et al., 1995; Morral, et al., 1997). Weak and equivocal predictors such as these provide little value to treatment providers who wish to identify clients at a high risk for poor treatment response. Although pre-treatment characteristics have little predictive value, several studies suggest it might be possible to predict treatment response based on patients drug use in the days immediately preceding treatment admission (McLellan et al., 1997). For example, Alterman et al. (1997) found that the urine specimens provided by clients at admission could be used to predict treatment response in four samples of clients receiving different treatments for cocaine dependence. Across samples, of the 107 clients who completed treatment, 79% submitted a cocaine-free baseline urine, compared to only 39% of the 132 clients who did not complete their respective treatments. Similarly, among the 123 who succeeded in submitting at least three consecutive cocaine-free urine samples during treatment (not including the baseline sample), 77% had submitted a cocaine-free baseline sample, compared to just 41% of the 133 clients who never achieved initial cocaine abstinence. Whereas the foregoing studies examined client factors that could be known at treatment admission, client performance in the first weeks of treatment offers an especially promising set of predictors of treatment response in subsequent months. Using a sample of 169 methadone maintenance patients, Morral et al. (1997) showed that 41 of 43 treatment dropouts (84%) were found among those clients who failed to achieve abstinence from illicit drugs during the first month in treatment. Similarly, in a study of outpatient treatment for cocaine, Budney et al. (1996) compared patients who did and did not achieve early cocaine abstinence, as shown by submitting three cocaine-negative urine specimens during the second week of treatment. Over the first 24 weeks of treatment, they found significantly lower rates of cocaine use and greater treatment retention among the early abstainers. In this study we examine whether outcomes 6 or 9 months after treatment entry can be accurately predicted by objective measures of treatment performance that are commonly available to clinics within the first 2 weeks of methadone treatment. This time interval was selected to balance the competing interests of early identification (i.e. before large commitments of time and resources are devoted to treatment) with the enhanced predictive value of later treatment performance. Significant treatment dropout typically occurs in the first weeks and months of treatment and it would be clinically useful to identify potential drop-outs before they leave treatment. Furthermore, data from the first week in treatment could be misleading since some patients transfer into methadone treatment from brief periods of inpatient treatment, and evidence of pretreatment drug use might remain in subject s urine samples during this week. 2. Method 2.1. Participants Participants were 59 methadone maintenance patients taking part in a treatment outcome study of the effectiveness of a contingency management intervention (Iguchi et al., 1997a). All participants were admitted to methadone maintenance treatment at the Philadelphia Veterans Affairs Medical Center (PVAMC) between April and November The sample represents consecutive admissions except for 21 patients not included in the sample. Of those excluded, 11 refused to participate in the treatment outcome study, three left treatment within 1 week of admission, two failed to complete research admission assessments within 1 week of admission; three were excluded because of serious medical problems; two patients initially admitted to the study were subsequently removed because of repeated inpatient medical and psychiatric hospitalizations during the course of treatment. A total of 95% of the 59 study participants were male; 68% were black, and 32% white. Participants ranged in age from 24 to 66 years (M=43.6 years). Of these, 29% of participants reported full-time employment; 39% were unemployed; 2% were homemakers; 20% received disability payments; 8% reported occasional or part-time employment; and 2% were retired. Participants reported a mean of 15.9 years of regular (at least three times per week) heroin use, and 5.8 years of regular cocaine use before admission Treatment On admission, consenting patients were randomly assigned to receive either standard methadone mainte-
4 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) nance treatment (standard; n=30) or a token economy intervention (token; n=29). Token group participants earned vouchers for providing urine specimens testing negative for unauthorized drugs (drug-free urines), and for providing objective evidence of completing tasks individually tailored to each clients treatment plan. For instance, a client working toward the treatment plan goal of taking on more parental responsibility might be assigned the task of attending a forthcoming parent teacher conference and bringing materials from this meeting to the counselor. Participants in this condition could earn vouchers worth up to $20 that could be redeemed for goods and services approved by their counselors. Except that the participants in the token condition were assigned tasks and had the opportunity to earn vouchers, the standard and token treatment conditions were identical. All patients were scheduled to meet with their counselors a minimum of once a week throughout the intervention. These study procedures and the consent forms used were approved by the institutional review boards of the VA hospital and Allegheny University of the Health Sciences. Analysis of results over the first 6 months of the study indicated that the token intervention had no significant effect on any measured outcome variables including urinalysis results (Iguchi et al., 1997a) Measures Addiction se erity index (ASI) The ASI is a structured interview assessing recent drug and alcohol use (past 30 days) as well as problem severity in five other target areas: medical status, employment status, legal status, family/social relationships and psychiatric symptoms. The measure has proven reliable and valid in a variety of studies (McLellan et al., 1985; Kosten et al., 1983; McLellan et al., 1992). In this study, ASI interviews were conducted at treatment admission and again at months 3, 6 and Urinalysis results Urine samples were collected twice weekly on a random basis from all participants. Specimens were collected under staff observation to ensure authenticity. Specimens were subjected to on-site enzyme multiplied immunoassay technique analysis (Behring-Syva, Palo Alto, CA) to test for recent use of methadone, illicit opiates, benzodiazepines, cocaine, THC, amphetamines and barbiturates. Analyses focused on urinalysis results in week 2 and in months 6 and 9 of treatment (i.e. weeks and weeks 33 36) Week 2 performance Attendance of scheduled counseling sessions and results of week 2 urinalyses were used as objective indices of treatment performance in week 2. By the end of week 2, all participants were scheduled to attend at least two counseling sessions. Amphetamines and barbiturates were detected in 5% or less of the week 2 urine samples, so were not considered as predictors of treatment outcome for this study. Similarly, every patient was positive for methadone, so this variable was excluded. Although participants could have zero, one or two urine specimens test positive for each assay in week 2, the distribution of positive assays was bimodal; for each assay, all but six or fewer participants were positive in all or none of their week 2 urine samples. Therefore, week 2 measures for use of illicit opiates, cocaine, THC, and benzodiazepines were dichotomized as abstinent or not abstinent Outcomes at 6 and 9 months We combined information on treatment dropout and objective data on participants continued use of illicit opiates and cocaine to create two dichotomous measures, 6-month and 9-month outcomes. Participants were described as having superior outcomes at 6 or 9 months if they remained in treatment until the end of month 6 or 9, respectively, and if fewer than four of the eight urines samples submitted during months 6 or 9 revealed use of illicit opiates or cocaine. Poor 6 month outcomes were assigned to clients who dropped out before the end of month 6, or whose urine samples during month 6 were positive for opiates or cocaine on at least four of the eight occasions. Similarly, poor 9 month outcomes were assigned to clients who dropped out before the end of month 9 or submitted four or more urine samples revealing use of cocaine or illicit opiates during month 9. We used urine results from just month 6 or month 9, rather than from the entire 6 or 9 month duration of treatment, so that our measure of outcome would be sensitive to those participants who improved, but only after several months of inferior performance. This composite measure of treatment outcomes is subject to the criticism that some clients who dropped out of methadone treatment might have become drugfree or had other positive outcomes, in which case classifying all dropouts as having inferior outcomes would be misleading. However, counting dropout as an inferior outcome is supported by the frequent finding that treatment dropout in the first year is associated with high rates of relapse to intravenous heroin use (Simpson, 1979; Ball and Ross, 1991; Simpson et al., 1997). Since methadone treatment is primarily designed to treat opiate use disorders, not cocaine use, including cocaine use in our definition of methadone treatment response could also be considered unwarranted. We chose to include cocaine use because only the pharmacotherapy offered in methadone maintenance treatment targets opiate use exclusively. Individual counseling, group and family therapy, psychoeducation and self-
5 28 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) help components of the treatment are designed to eliminate all illicit substance use. Ongoing cocaine use compromises the success of these components of methadone maintenance therapy. Furthermore, the strong association routinely found between cocaine use and illicit opiate use among methadone patients makes cocaine use a clear risk factor for relapse to heroin use (Kosten et al., 1988; Dunteman et al., 1992; Hartel et al., 1995). Finally, our decision to dichotomize outcomes resolved several measurement problems. First, there is no good way to estimate opiate and cocaine use among the dropouts, but treatment dropout in the first 6 to 9 months is usually associated with poor outcomes (Simpson, 1979; Ball and Ross, 1991; Simpson et al., 1997). Second, among participants remaining in treatment, opiate and cocaine use was moderately correlated (r=0.56 and 0.53, for months 6 and 9, respectively). And third, neither opiate nor cocaine use was normally distributed. Indeed, in months 6 and 9, these measures were bimodally distributed, with 71 81% of all participants submitting urine samples that were nearly all drug free (zero or one sample out of eight testing positive for cocaine or illicit opiates) or nearly all drug positive (seven or eight of eight testing positive for cocaine or illicit opiates) Procedure We used a blocked, step-wise logistic regression procedure to assess whether outcomes could be predicted by pre-treatment patient characteristics or by early treatment performance. Patient pre-treatment characteristics and experimental group assignment were entered in the first block. Week 2 performance measures were entered in the second block to determine whether they improved prediction of performance beyond what could be explained by pre-treatment factors alone. Our 6 and 9 month outcome measures treat all dropouts as inferior outcomes, even though some might have done well after dropping out. Furthermore, they are insensitive to reductions in drug use that fall short of abstinence. Thus, we conducted secondary analyses in which self-reports of the number of days of cocaine and heroin use at follow up were regressed onto the early treatment indicators found useful in the prediction of our outcome classifications. We succeeded in following up and interviewing 86 and 80% of the sample at the 6 and 9 month assessments, respectively. Whereas our follow up of clients who were still in treatment was nearly perfect (98 and 100%), follow up for dropouts was considerably lower (59 and 45%). We approached this missing data problem in two ways, both of which are conservatively designed to reduce the likelihood of finding statistical significance when no true relationship exists between the predictors and outcomes (type I errors). First, we replaced missing values with the value provided by participants at their last completed interview. This interpolation procedure adopts the unrealistic assumption that dropouts do not increase their use of heroin and cocaine. Because this assumption obscures the negative outcomes associated with dropout, it leads to range restrictions that present a greater challenge to our predictive model than might reasonably be expected had we successfully interviewed all dropouts. In the second procedure we evaluate the predictive model using only those subjects we successfully interviewed. This procedure reduces the power of the predictive model to detect genuine associations between week 2 performance and outcomes, because it reduces the sample size and restricts the range of outcomes. For the 6 and 9 month outcome models we report the results of analyses conducted using both missing data procedures. 3. Results 3.1. Outcome groups Table 1 describes the outcome status assigned to study participants at 6 and 9 months. Among participants who remained in treatment, but had inferior outcomes, more than half submitted 100% opiate positive urine specimens in month 6 and 9. Only one participant in month 6 and five in month 9 were classed as inferior outcomes because of their cocaine use alone. Among those in the superior outcome group, the majority (56% in month 6 and 57% in month 9) did not submit a single urine specimen testing positive for cocaine or opiates. Thus, most participants were either consistently drug-free in month 6 and 9 or consistently used opiates or opiates and cocaine. Characterizing outcomes on the basis of treatment retention and urinalysis results was supported by selfreports of drug use made by the 47 participants (80%) Table 1 Outcome classifications at months 6 and 9 Month 6 Month 9 n % n % Superior outcome Inferior outcome Drop out a Substance use b Total a The subsets of clients with inferior outcomes because they dropped out of treatment. b The subset of clients with inferior outcomes because they continued to abuse heroin or cocaine.
6 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) interviewed at 6 and 9 months. Among the 33 participants interviewed at month 9 from the inferior outcome group, the average frequency of heroin use fell significantly from days of use at admission to 7.91 days at month 9, t(32)=7.06, P The superior outcomes group, however, showed a 97% reduction over the same period, reducing their use from days at admission to just 0.07 days at month 9, P Similarly, although the frequency of cocaine use diminished slightly in the inferior group (from 8.73 to 6.70 days of use, t[32] =1.09, n.s.), the superior outcome group reduced their cocaine use frequency by 98% (from 5.93 to 0.07 days of use, t[13]=3.09, P 0.01). An identical pattern of self-reported cocaine and heroin use was found for the 6 month outcomes. Finally, among clients with inferior outcomes, frequencies of cocaine and heroin use at follow-up were higher for participants who dropped out of treatment than for those remaining in treatment, but these differences were not statistically significant Week 2 performance During week 2, urinalysis results indicated that 25 participants (42%) were opiate abstinent, 29 (49%) were cocaine abstinent, 35 (59%) were THC abstinent, and 53 (90%) were benzodiazepine abstinent. Of the 47 participants continuing to use illicit drugs, nearly half (49%) were using both cocaine and illicit opiates. By the end of week 2, participants attended a mean of 1.46 counseling sessions. Seven participants attended no scheduled sessions, 23 attended one session, 25 attended two sessions, three attended three sessions and one participant attended four sessions. To reduce the effect of the four clients who had more than the scheduled number of counseling sessions, this variable was dichotomized between those who did, versus did not attend at least two counseling sessions in the first 2 weeks of treatment Predicting treatment response at 6 and 9 months We evaluated the usefulness of the week 2 performance measures for predicting treatment outcomes by including all five (counseling attendance and abstinence from four drug classes) in the second block of a forward stepwise logistic regression procedure. The first block contained variables that could be known about participants at treatment entry: patient demographic characteristics (age and race), pre-treatment characteristics derived from the admission ASI (days of heroin use, days of cocaine use, days of THC use, days of sedative use, days of alcohol use, days of employment, years of heroin use, years of cocaine use, and composite scores from the six non-drug problems areas: alcohol, family, employment, legal, medical and psychiatric), Table 2 Estimated coefficients, estimated standard errors and odd ratios for the multivariate model predicting outcome classifications Term Estimate S.E. P Odds (95% CI) Parameter estimates for positi e 6-month outcomes Week 2 opiate ab (1.99 stinence 48.30) Week 2 attendance ( ) Parameter estimates for positi e 9-month outcomes Age ( ) Week 2 opiate ab (1.19 stinence 49.81) Week 2 atten (1.87 dance 87.16) and experimental group assignment (from the parent study from which this sample derives). Unscorable responses led to one missing value on the ASI employment and four missing values for the ASI legal severity composite scores. For the regressions reported below, replacing these five missing values with sample means or excluding the incomplete variables from the analyses led to identical results. After the first block of variables was entered in the month 6 outcomes regression, no variables were retained in the equation. Entry of the second block resulted in a significant two-covariate solution, likelihood-ratio 2 (2, n=59)=22.25, P Week 2 opiate abstinence and week 2 counseling attendance each contributed significantly and independently to the prediction of outcome classification (Table 2). After controlling for counseling attendance, the odds of a positive 6-month outcome were almost ten times greater for participants who were opiate abstinent by week 2 than for those who submitted at least one urine sample testing positive for illicit opiates. Similarly, attending at least two counseling sessions improved clients odds of a good 6 month outcome by a factor of more than 11. This two factor model fit the observed outcomes well, correctly classifying the treatment responses of 83% of the sample. Its specificity (correct identification of participants with inferior outcomes) was 89%, and its sensitivity (correct identification of participants with superior outcomes) was 66%. Of the 20 patients who did not attend at least two counseling sessions and who were not opiate abstinent in week 2, not one was in the superior outcome group at 6 months. On the other hand, of the 15 patients who were opiate abstinent and attended at least two sessions by the end of week 2, two-thirds (ten) had positive outcomes. Finally, we reestimated the model including a term for the interaction of week 2 opiate abstinence and counseling attendance, which did not result in a significant improvement for the model.
7 30 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) Table 3 Estimated coefficients for week 2 performance predictors of self-reported drug use at follow up with drop outs omitted and dropouts interpolated Dependent variable Parameter estimates Model Opiate abstinence (S.E.) Counseling attendance (S.E.) R 2 F 7.95 (2.51) 0.30 Outcomes at month 6 Days of heroin use 7.04 (2.55) 10.21*** Dropouts omitted a Days of cocaine use 4.95 (2.78) 5.88 (2.74) * Days of heroin use 8.86 (2.50) 7.51 (2.47) *** Dropouts interpolated b Days of cocaine use Outcomes at month 9 Dropouts omitted a Days of heroin use 4.61 (2.49) 4.68 (1.89) 4.97 (2.46) 4.74 (1.86) * 7.57** Days of cocaine use 1.09 (2.11) 4.44 (2.08) Days of heroin use 5.02 (2.20) 7.24 (2.18) *** Dropouts interpolated b Days of cocaine use 1.97 (2.30) 5.24 (2.28) * a For 6 month models, n=51 and df=2,48. For 9 month models, n=47 and df=2,44. b For both 6 and 9 month models, n=59 and df=2,56. * P ** P *** P When we repeated the foregoing regression procedures on the month 9 outcome data, age survived the first block and week 2 opiate abstinence and counseling attendance again survived the second block (Table 2). This final regression model was highly significant, likelihood ratio 2 (3, n=59)=21.69, P Model fit was again good, correctly classifying 86% of all clients; sensitivity of the model was 50%, and the specificity was 98%. Opiate abstinence in week 2 again demonstrated a significant independent contribution to explaining the likelihood of superior 9-month treatment outcomes. Those who achieved abstinence by the second week of treatment were more than seven times as likely to remain in treatment and be using little or no cocaine or illicit opiates 9 months after treatment entry, when controlling for age and counseling attendance. Similarly, participants who attended two counseling sessions by the end of the second week of treatment were more than 12 times as likely to have superior 9 month outcomes. Indeed, of the 30 participants who attended fewer than two counseling sessions, only two had superior 9-month outcomes. The effect of age on treatment outcomes was comparatively slight. Controlling for the week 2 performance indicators, for every year older our participants were, their chances of having a superior 9 month outcome improved 17%. This means that other factors being equal, the likelihood of a superior outcome would be about five times greater for participants who are 35 than those who are Predicting self-reported drug use at 6 and 9 months Table 3 presents the regression coefficients for week 2 opiate abstinence and treatment attendance for each of the self-reported drug use outcomes. Week 2 measures of opiate abstinence and counseling attendance were excellent predictors of both the frequency of heroin use and cocaine use at the 6 month outcome assessments. Moreover, this proved to be true both for analyses excluding subjects with missing data, and for those analyses that interpolated missing data based on subjects last reported drug use frequencies. For each model, opiate abstinence and counseling attendance by week 2 were associated with large reductions in the number of days of cocaine and heroin use reported half a year later by participants. For 9 month outcomes, all associations were significant, except for one model of cocaine use self-reports at 9 months. Similarly, in a series of secondary analyses we found that counseling attendance and opiate abstinence accounted for these drug use outcomes beyond what could be explained by self-reported use at program admission. That is, adding the early treatment indicators to regression models containing just self-reported use at admission resulted in significant increments in explained variance for all cocaine and heroin use outcomes except cocaine use at 9 months (interpolated and noninterpolated). With the exception of the 9-month model, the least significant
8 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) finding was for interpolated 6-month cocaine use; in this model week-2 predictors increased explained variance by 0.11, F(2,55)=5.96, P Discussion Although pretreatment characteristics have not proven to be robust predictors of treatment response, the results of this study suggest that 6 and 9 month treatment outcomes can be predicted using objective measures of treatment response that are available to providers within 2 weeks of program admission. Specifically, opiate abstinence and counseling attendance by the second week of treatment were better predictors of treatment response by months 6 and 9 than were our pretreatment variables, and together they could be used to correctly classify 90% of clients who went on to have inferior treatment responses, with an overall correct classification rate of well over 80%. In secondary analyses, these two variables also accounted for a large portion of variance in self-reported heroin and cocaine use 6 and 9 months after treatment entry. Our finding that counseling attendance in the first weeks of treatment predicts treatment response in the ensuing three quarters of a year can be interpreted in several ways. Early counseling attendance could serve as a marker of those clients with greater treatment motivation or greater treatment compliance, each of which could contribute to superior treatment outcomes. Furthermore, to the extent that the counselor is an active ingredient in the treatment process, greater attendance early in treatment corresponds to an increased dose of treatment, and might thereby result in superior treatment outcomes months later. The predictive value of opiate abstinence in the second week of treatment corresponds to other recent findings indicating that drug use early in treatment predicts poor outcomes (Budney et al., 1996; Alterman et al., 1997; Morral et al., 1997). Our finding that opiate abstinence in the second week of treatment predicts treatment response in the ensuing three quarters of a year can be interpreted similarly. Early abstinence may serve as a marker for greater treatment motivation or treatment compliance. It may also be that individuals demonstrating abstinence early in treatment receive strong social support and reinforcement for their behavior, leading to an increase in that response. Regardless of mechanism, the predictive value of opiate abstinence in the second week of treatment corresponds to other findings indicating that drug use early in treatment predicts poor outcomes (Budney, et al., 1996; Alterman et al., 1997; Morral et al., 1997). As noted earlier, our decision to include dropouts and cocaine users among those in the inferior outcome group could raise theoretical objections. We note, however, that this decision was strongly supported by the present results. First, the association of regular cocaine use with regular heroin use was so great that only one participant received the inferior outcome classification at month 6 on the basis of cocaine use alone. Second, participants who dropped out of treatment reported using heroin more frequently than others in the inferior response group, a group which on average was using heroin more than 25 times as often per month as the superior outcome group. Although we were unable to interview a portion of the dropouts, it is likely that if our follow-up cohort offers a biased sample of dropouts, the bias would lead to underestimates of actual drug use among dropouts, not overestimates. Our inferior outcome designation should be understood in the context of the relative rates of improvement among all clients. Even among the inferior outcome group, rates of heroin use after treatment entry were significantly lower than immediately prior to treatment. A total of 6 months after treatment entry, clients with inferior outcomes reported using heroin on half as many days as in the month preceding treatment entry. Therefore, methadone treatment was associated with a substantial reduction in risk behaviors even among this group. Nevertheless, participants classed as having inferior outcomes, who constitute more than three-quarters of our sample, continued to use heroin and cocaine at unacceptably high rates, even after 9 months of a methadone treatment in which they received peak methadone doses averaging over 79 mg and ranging up to 130 mg. Thus, our results demonstrate that although methadone treatment was partially effective for the majority in our sample, there is a great need for alternative or auxiliary interventions. The present findings suggest a simple technique that might prove useful in community methadone treatment settings for the early identification of clients at greatest risk for dropout or continued use of heroin and/or cocaine. If opiate abstinence and attendance of at least 2 weekly counseling sessions by the second week of treatment are counted as distinct protective factors against inferior treatment response, clients can be considered high risk for dropout or continued drug use if they have neither protective factor, moderately high risk if they have only one, and only moderate risk if they have both. Using these criteria with the present sample, 34% would have been classed as high risk, of whom 100% had inferior 6 month outcomes; another 41% would have been classed as at moderately high risk, of whom 79% had inferior outcomes; and the remaining 25% would have been classed as having only moderate risk, of whom 33% had inferior 6 month outcomes. Since clients might be especially willing to acknowledge continued use of opiates early in their methadone treatment, this proposed procedure might not require expensive urinalyses.
9 32 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) The contingency management intervention used in the parent study was not found to significantly increase participants chances of achieving a superior treatment outcome. Nevertheless, other contingency management interventions are among the few special interventions that appear promising for clients who are not substantially improving early in treatment. Morral et al. (1997), for instance, found that for clients whose initial response to treatment was relatively poor, the best predictor of subsequent superior performance was whether or not the client later received a contingency management intervention. Clients provided with clearly defined incentives for reducing their drug use or making progress toward other treatment plan goals were more than ten times as likely to show marked improvement during their methadone treatment. Furthermore, these improvements were rapid and appeared to begin immediately after the contingency management interventions were implemented. There is also substantial evidence that well designed contingency management interventions can reduce drug use and increase counseling attendance (Kidorf et al., 1994; Rowan-Szal et al., 1994; Iguchi et al., 1996; Silverman et al., 1996a,b; Iguchi et al., 1997b), the two factors found in the present study to best predict superior treatment outcomes. Despite the apparent predictive validity of opiate use and counseling attendance in the second week of treatment, limitations of this study suggest the need to further evaluate these factors. First, the sample size in the present study was small and not selected in such a way as to ensure the generalizability of our findings to other populations of methadone patients. Our sample chiefly consisted of male veterans in Philadelphia. Whether the week 2 performance factors we identified will have predictive utility in other samples of methadone clients remains to be studied. Furthermore, the stepwise regression procedure we used to identify outcome predictors can be criticized for increasing the likelihood of finding chance associations in a sample when the true association in the population is actually weaker. The wide variation in methadone treatment outcomes highlights the need for identifying those subgroups of clients for whom standard care will be more or less effective. Identifying these subgroups could improve treatment planning and facilitate development of new treatment interventions better matching the needs of clients who are unlikely to have superior treatment responses. The enormous potential value which such identifiers might have is suggested, in part, by the literally hundreds of studies that have sought them among demographic, drug use history, and other client factors. Unfortunately, these studies have not yielded robust predictors of methadone treatment response. In this study we found that early treatment response, during the first 2 weeks following admission, provides a powerful predictor of later treatment performance. In particular, opiate abstinence in the second week of treatment and the number of counseling sessions attended by the second week were shown to correctly classify the treatment performance of 83% of our sample 6 and 9 months later. These findings suggest that although client characteristics at program admission might provide little guidance in treatment planning, client performance early in treatment might offer an especially powerful indicator that could be used to guide subsequent treatment planning. Acknowledgements This research was supported by Nation Institute on Drug Abuse grants R01 DA06096 (Iguchi), R01 DA10778 (Iguchi) and P50 DA07705 (McLellan). The data reported in this article were collected by our research assistants, Rebecca Fidler-Sheppard and Karen Mosher-Waite, whose dedication and careful work we gratefully acknowledge. Mark Belding is now at Allan Collautt Associates, 1974 Sproul Road, Suite 200, Broomall, PA References Alterman, A.I., Kampman, K., Boardman, C.R., Cacciola, J.S., Rutherford, M.J., McKay, J.R., Maany, I., Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend. 46, Ball, J.C., Ross, A., The Effectiveness of Methadone Maintenance Treatment. Springer, New York. Belding, M.A., Iguchi, M.Y., Lamb, R.J., Lakin, M., Terry, R., Stages and processes of change among polydrug users in methadone maintenance treatment. Drug Alcohol Depend. 39, Belding, M.A., McLellan, A.T., Zanus, D.A., Incmikoski, R., Characterizing non-responsive methadone patients. J. Subst. Abuse Treat. 15, 1 8. Budney, A.J., Higgins, S.T., Wong, C., Bickel, W.K., Early abstinence predicts outcome in behavioral treatment for cocaine dependence. In: Harris, L.S. (Ed.), Problems of drug dependence, 1995: Proceedings of the 57th annual scientific meeting, NIDA research monograph. National Institute on Drug Abuse, Rockville, MD. Cacciola, J.S., Alterman, A.I., Rutherford, M.J., McKay, J.R., McLellan, A.T., The early course of change in methadone maintenance. Addiction 93, Dunteman, G.H., Condelli, W.S., Fairbank, J.A., Predicting cocaine use among methadone patients: analysis of findings from a national study. Hosp. Community Psychiatry 43, GAO, Methadone maintenance: some treatment programs are not effective; greater Federal oversight needed. United States General Accounting Office, Washington, DC, GAO/HRD Hartel, D.M., Schoenbaum, E.E., Selwyn, P.A., Kline, J., et al., Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am. J. Public Health 85, Hubbard, R.L., Marsden, M.E., Rachal, J.V., Harwood, H.J., Ginzburg, H.M., Drug Abuse Treatment: A National Study
10 A.R. Morral et al. / Drug and Alcohol Dependence 55 (1999) of Effectiveness. University of North Carolina Press, Chapel Hill, NC. Iguchi, M.Y., Lamb, R.J., Belding, M.A., Platt, J.J., Husband, S.D., Morral, A.R., Contingent reinforcement of group participation versus abstinence in a methadone maintenance program. Exp. Clin. Psychopharmacol. 4, Iguchi, M.Y., Belding, M.A., Morral, A.R., Lamb, R.J., Woody, G.E., 1997a. A token economy intervention for methadone maintenance patients. In: Harris, L.S. (Ed.), Problems of drug dependence, 1996: Proceedings of the 58th annual scientific meeting, NIDA research monograph 174. National Institute on Drug Abuse, Rockville, MD, p Iguchi, M.Y., Belding, M.A., Morral, A.R., Lamb, R.J., Husband, S.D., 1997b. Reinforcing operants other than abstinence: an effective alternative for reducing drug-use. J. Couns. Clin. Psychol. 65, Kidorf, M., Stitzer, M.L., Brooner, R.K., Goldberg, J., Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend. 36, Kosten, T.R., Rounsaville, B.J., Kleber, H.D., Concurrent validity of the Addiction Severity Index. J. Nerv. Ment. Dis. 171, Kosten, T.R., Rounsaville, B.J., Kleber, H.D., Antecedents and consequences of cocaine abuse among opioid addicts: a 2.5-year follow-up. J. Nerv. Ment. Dis. 176, McLellan, A.T., Patient characteristics associated with outcome. In: Cooper, J.R., Altman, F., Brown, B.S., Czechowicz, D. (Eds.), Research on the Treatment of Narcotic Addiction: State of the Art. (NIDA Treatment Research Monograph Series, DHHS publication no. ADM ). US Government Printing Office, Washington, DC, pp McLellan, A.T., Luborsky, L., Woody, G.E., O Brien, C.P., Druley, K.A., Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch. Gen. Psychiatry 40, McLellan, A.T., Luborsky, L., Cacciola, J., Griffith, J.E., New data from the Addiction Severity Index: reliability and validity in three centers. J. Nerv. Ment. Dis. 173 (7), McLellan, A.T., Alterman, A.I., Cacciola, J., Metzger, D., O Brien, C.P., A new measure of substance abuse treatment: initial studies of the treatment services review. J. Nerv. Ment. Dis. 180 (2), McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., O Brien, C.P., The effects of psychosocial services in substance abuse treatment. J. Am. Med. Assoc. 269 (15), McLellan, A.T., Alterman, A.I., Metzger, D.S., Grissom, G.R., Woody, G.E., Luborsky, L., O Brien, C.P., Similarity of outcome predictors across opiate, cocaine and alcohol treatments: role of treatment services. J. Consult. Clin. Psychol. 62 (6), McLellan, A.T., Alterman, A.I., Metzger, D.S., Grissom, G.R., Woody, G.E., Luborsky, L., O Brien, C.P., Similarity of outcome predictors across opiate cocaine and alcohol treatments: role of treatment services. J. Consult. Clin. Psychol. 62, Morral, A.R., Iguchi, M.Y., Belding, M.A., Lamb, R.J., Natural classes of treatment response. J. Consult. Clin. Psychol. 65, Nunes, E.V., Coyne, T.H., Young, S., Hoffman, M., Woytek, R., Bertino, L., Kroger, J., Amann, K., Group psychotherapy for treatment refractory methadone maintenance patients: a clinical experience. J. Maint. Addict. 1, Phillips, C.D., Hubbard, R.L., Dunteman, G., Fountain, D.L., Czechowicz, D., Cooper, J.R., Measuring program performance in methadone treatment using in-treatment outcomes: an illustration. Special section: Outcomes research. J. Ment. Health Adm. 22 (3), Rowan-Szal, G., Joe, G.W., Chatham, L.R., Simpson, D.D, A simple reinforcement system for methadone clients in a community-based treatment program. J. Subst. Abuse Treat. 11, Saxon, A., Fleming, C., Jackson, T.R., Wells, E., Calsyn, D.A., Predictors of Methadone Treatment Outcome. NIDA Research Monograph Series 153, 143. Silverman, K., Higgins, S.T., Brooner, R.K., Montoya, I.D., Cone, E.J., Schuster, C.R., Preston, K.L., 1996a. Sustained cocaine abstinence in methadone maintenance patients through voucherbased reinforcement therapy. Arch. Gen. Psychiatry 53, Silverman, K., Wong, C., Higgins, S.T., Brooner, R.K., Montoya, I.D., Contoreggi, C., Umbricht-Schneiter, A., Schuster, C.R., Preston, K.L., 1996b. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41, Simpson, D.D., The relation of time spent in drug abuse treatment to posttreatment outcome. Am. J. Psychiatry 136, Simpson, D.D., Joe, G.W., Rowan-Szal, G.A., Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 47, Stitzer, M.L., Iguchi, M.Y., Felch, L.J., Contingent take-home incentives: effects on drug use of methadone maintenance patients. J. Consult. Clin. Psychol. 60,
Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach. Van L. King, MD
Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach Van L. King, MD UT Health, Department of Psychiatry Grand Rounds November 15, 2016 Addiction Treatment
More informationEffects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients
Blackwell Science, LtdOxford, UKADDAddiction1360-0443 2003 Society for the Study of Addiction to Alcohol and Other Drugs98665671Original ArticleContingency management and desipramine for cocaine Thomas
More informationTreatment retention has served. Relationships Between Counseling Rapport and Drug Abuse Treatment Outcomes
Relationships Between Counseling Rapport and Drug Abuse Treatment Outcomes George W. Joe, Ed.D. D. Dwayne Simpson, Ph.D. Donald F. Dansereau, Ph.D. Grace A. Rowan-Szal, Ph.D. Objective: This study examined
More informationThe Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence
The Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence John S. Cacciola, Arthur I. Alterman, Charles P. O Brien, and A. Thomas McLellan INTRODUCTION The Addiction
More informationCHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION
CHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION Fisher ch.27 Drug addiction is a very prevalent issue in the current United States society. The substance abuse treatments that are available
More informationAssessing Outpatient Drug Abuse
_ Articles Assessing Outpatient Drug Abuse Treatment Programs FRANK M. TIMS, ARTHUR M. HORTON, JR., BENNETT W. FLETCHER, and RICHARD H. PRICE Drug abuse is a major domestic health problem in the United
More informationORIGINAL ARTICLE. Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence
ORIGINAL ARTICLE Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence Efficacy of Contingency Management and Significant Other Involvement Kathleen M. Carroll, PhD; Samuel
More informationSelected In-Treatment Outcomes of Long-Term Methadone Maintenance Treatment Patients in New York State
Selected In-Treatment Outcomes of Long-Term Methadone Maintenance Treatment Patients in New York State PHILIP W. APPEL, PH.D., HERMAN JOSEPH, PH.D., ALAN KOTT, M.A., WILLIAM NOTTINGHAM, M.A., EDWARD TASINY,
More informationApplying Behavioral Theories of Choice to Substance Use in a Sample of Psychiatric Outpatients
Psychology of Addictive Behaviors 1999, Vol. 13, No. 3,207-212 Copyright 1999 by the Educational Publishing Foundation 0893-164X/99/S3.00 Applying Behavioral Theories of Choice to Substance Use in a Sample
More informationThe role of behavioral interventions in buprenorphine treatment of opioid use disorders
The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies
More informationImproving Outcomes in Methadone Treatment
Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions COMP Symposium September 11, 2007 Overview of Presentation
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationCenterstone Research Institute
American Addiction Centers Outcomes Study 12 month post discharge outcomes among a randomly selected sample of residential addiction treatment clients Centerstone Research Institute 2018 1 AAC Outcomes
More informationAmerican Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute
American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients Centerstone Research Institute 2018 1 AAC Outcomes Study: Long-Term Outcomes Executive Summary
More informationDesipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients
Drug and Alcohol Dependence 70 (2003) 315/325 www.elsevier.com/locate/drugalcdep Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients Thomas Kosten
More informationEvidence-Based Practice: Psychosocial Interventions
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?
More information2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders
The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,
More informationSubstance use and perceived symptom improvement among patients with bipolar disorder and substance dependence
Journal of Affective Disorders 79 (2004) 279 283 Brief report Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence Roger D. Weiss a,b, *, Monika
More informationRESEARCH REPORT ABSTRACT
RESEARCH REPORT doi:1.1111/j.136-443.11.349.x Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in Chinaadd_349 181..189
More informationThe Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders
AM. J. DRUG ALCOHOL ABUSE, 26(3), pp. 369 378 (2000) The Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders Roger D. Weiss, M.D.* Shelly F. Greenfield, M.D., M.P.H. Margaret
More informationTHE 2001 ANNUAL report of
ORIGINAL ARTICLE A National 5-Year Follow-up of Treatment Outcomes for Cocaine Dependence D. Dwayne Simpson, PhD; George W. Joe, EdD; Kirk M. Broome, PhD Background: Long-term (5-year) outcomes of community
More informationBuprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing
Drug and Alcohol Dependence 77 (2005) 195 204 Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing Lisa A. Marsch a,c,, Warren K. Bickel a,e, Gary
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationTITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness
TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness DATE: 08 October 2009 CONTEXT AND POLICY ISSUES: Poly-drug abuse is
More informationOutcomes Monitoring System Iowa Project
Outcomes Monitoring System Iowa Project Year Six Report Prepared By: Iowa Consortium for Substance Abuse Research and Evaluation University of Iowa, Iowa City, Iowa 52242-5000 With Funds Provided By: Iowa
More informationOutcomes Monitoring System Iowa Project
Outcomes Monitoring System Iowa Project Year Seven Report Prepared By: Iowa Consortium for Substance Abuse Research and Evaluation University of Iowa, Iowa City, Iowa 52242-5000 With Funds Provided By:
More informationORIGINAL ARTICLE. A 33-Year Follow-up of Narcotics Addicts. Yih-Ing Hser, PhD; Valerie Hoffman, PhD; Christine E. Grella, PhD; M. Douglas Anglin, PhD
ORIGINAL ARTICLE A 33-Year Follow-up of Narcotics Addicts Yih-Ing Hser, PhD; Valerie Hoffman, PhD; Christine E. Grella, PhD; M. Douglas Anglin, PhD Background: This study examined longitudinal patterns
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationFinal Evaluation Report
The Louisiana Access to Recovery Project Final Evaluation Report Access to Recovery II: 2007-2010 Prepared for: Louisiana Department of Health and Hospitals (DHH) Office of Behavioral Health Author: Laurel
More informationOverview of Treatment Engagement Findings from DATOS
Drug Abuse Outcome Studies (Funded by NIDA) Overview of Engagement Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),
More informationLUCAS COUNTY TASC, INC. OUTCOME ANALYSIS
LUCAS COUNTY TASC, INC. OUTCOME ANALYSIS Research and Report Completed on 8/13/02 by Dr. Lois Ventura -1- Introduction -2- Toledo/Lucas County TASC The mission of Toledo/Lucas County Treatment Alternatives
More informationSBIRT IOWA THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Iowa Army National Guard. Biannual Report Fall 2015
SBIRT IOWA Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Iowa Army National Guard Biannual Report Fall 2015 With Funds Provided By: Iowa Department of Public
More informationSBIRT IOWA. Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Iowa Army National Guard
SBIRT IOWA Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Iowa Army National Guard Biannual Report April 2017 With Funds Provided By: Iowa Department of Public
More informationIowa Army National Guard Biannual Report April 2016
SBIRT IOWA Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Iowa Army National Guard Biannual Report April 2016 With Funds Provided By: Iowa Department of Public
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January
More informationImproving Continuity of Care in a Public Addiction Treatment System with Clinical Case Management
The American Journal on Addictions, 14:426 440, 2005 Copyright # American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1080/10550490500247099 REGULAR ARTICLES Improving
More informationCONCURRENT USE OF ALCOHOL AND COCAINE: DIFFERENCES IN PATTERNS OF USE AND PROBLEMS AMONG USERS OF CRACK COCAINE AND COCAINE POWDER
Alcohol & Alcoholism Vol. 41, No. 2, pp. 121 125, 2006 Advance Access publication 2 February 2006 doi:10.1093/alcalc/agh260 CONCURRENT USE OF ALCOHOL AND COCAINE: DIFFERENCES IN PATTERNS OF USE AND PROBLEMS
More informationSBIRT IOWA. Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Iowa Army National Guard
SBIRT IOWA Iowa Army National Guard THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Iowa Army National Guard Biannual Report October 2016 With Funds Provided By: Iowa Department of Public
More informationReference List. Copyright 2007: Page 1 of 11
OPIOID-RELATED DISORDERS Reference List Allison, M., Hubbard, R.L. Drug abuse treatment process: a review of the literature. International Journal of the Addictions. 1985; 20(9):1321-1345. American Psychiatric
More informationCompliance Towards Methadone Maintenance Therapy and its Associated Factors in Selangor Primary Care Centers and Kuala Lumpur Hospital
ORIGINAL ARTICLE Compliance Towards Methadone Maintenance Therapy and its Associated Factors in Selangor Primary Care Centers and Kuala Lumpur Hospital W P Sharifa Ezat, MPH*, H Noor Azimah, MPH**, R Rushidi,
More informationPeople with serious mental illness. Outcomes of Critical Time Intervention Case Management of Homeless Veterans After Psychiatric Hospitalization
Outcomes of Critical Time Intervention Case Management of Homeless Veterans After Psychiatric Hospitalization Wesley J. Kasprow, Ph.D., M.P.H. Robert A. Rosenheck, M.D. Objective: This study evaluated
More informationOverview of. Treatment Outcome Studies from DATOS
Drug Abuse Treatment Outcome (Funded by NIDA) Overview of Treatment Outcome from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),
More informationDownloaded from:
Jofre-Bonet, M; Sindelar, JL; Petrakis, IL; Nich, C; Frankforter, T; Rounsaville, BJ; Carroll, KM (2004) Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients. Journal
More informationTreatment of Methamphetamine Dependence: Does Treatment Work?
Treatment of Methamphetamine Dependence: Does Treatment Work? Mary Lynn Brecht, Ph.D. Richard A. Rawson, Ph.D Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationVariability in Treatment-Seeking Cocaine Abusers: Implications for Clinical Pharmacotherapy Trials
Variability in Treatment-Seeking Cocaine Abusers: Implications for Clinical Pharmacotherapy Trials Kathleen M. Carroll, Charla Nich, and Bruce J. Rounsaville Variability in cocaine abusers seeking treatment
More information3/21/2015. Leonardo Andrade, Ph.D. Westfield State University
Leonardo Andrade, Ph.D. Westfield State University Evidence based behavioral treatment for drug abuse Theoretical foundation of CM is based on operant conditioning principles Contingencies associated with
More informationMOTIVATIONAL INCENTIVES FOR ENHANCED DRUG ABUSE RECOVERY: DRUG FREE CLINICS
NIDA-CTN-0006 MOTIVATIONAL INCENTIVES FOR ENHANCED DRUG ABUSE RECOVERY: DRUG FREE CLINICS Maxine Stitzer, Ph.D., Lead Investigator Nancy Petry, Ph.D. Co-Lead Investigator Robert Brooner, Ph.D. Co-Investigator
More informationIMPLICATIONS OF STUDY FINDINGS ON SUBSTANCE ABUSE TREATMENT SECTION SEVEN
IMPLICATIONS OF STUDY FINDINGS ON SUBSTANCE ABUSE TREATMENT SECTION SEVEN IMPLICATIONS OF STUDY FINDINGS ON SUBSTANCE ABUSE TREATMENT 51 IMPLICATIONS OF STUDY FINDINGS ON SUBSTANCE ABUSE TREATMENT The
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationState of Iowa Outcomes Monitoring System
State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 16 Annual Outcome Evaluation Trend Report November 2014 With Funds Provided By: Iowa Department
More informationTHE CURRENT NARCOTIC TREATment
ORIGINAL CONTRIBUTION Methadone Maintenance in Primary Care A Randomized Controlled Trial David A. Fiellin, MD Patrick G. O Connor, MD, MPH Marek Chawarski, PhD Juliana P. Pakes, MEd Michael V. Pantalon,
More informationEffectiveness and Cost-Effectiveness of Four Treatment Modalities for Substance Disorders: A Propensity Score Analysis
University of California, San Diego From the SelectedWorks of Joshua Graff Zivin 2003 Effectiveness and Cost-Effectiveness of Four Treatment Modalities for Substance Disorders: A Propensity Score Analysis
More informationState of Iowa Outcomes Monitoring System
State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 17 Annual Outcome Evaluation Trend Report November 2015 With Funds Provided By: Iowa Department
More informationOutlook and Outcomes Fiscal Year 2011
Baltimore Substance Abuse Systems, Inc. Outlook and Outcomes Fiscal Year 2011 Baltimore City Greg Warren, President Compiled July 2012 BSAS Outlook and Outcomes is the first edition of a planned annual
More informationDomestic Violence Inventory
Domestic Violence Inventory www.online-testing.com Domestic Violence Inventory Pre-Post The Domestic Violence Inventory Pre-Post or DVI Pre-Post is an objective and standardized test for domestic violence
More informationWe also Know INTEGRATED GROUP COGNITIVE BEHAVIORAL THERAPY FOR PATIENTS WITH CONCURRENT DEPRESSIVE AND SUBSTANCE USE DISORDERS
INTEGRATED GROUP COGNITIVE BEHAVIORAL THERAPY FOR PATIENTS WITH CONCURRENT DEPRESSIVE AND SUBSTANCE USE DISORDERS May 13, 2010 Kasia Galperyn, Ph.D., R. Psych. Kelly Rose, B.A. David Crockford, MD, FRCPC
More informationRECOMMENDATIONS FOR HEALTH CARE PROVIDERS
Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the
More informationTreatment Services Review
Agency Name: ID #: {Module Name} Module Date: / / Treatment Services Review Site Name: Date: / / TSR #: Last TSR Date: / / Interviewer ID: 1. Have you been in treatment during the past 14 days? This means
More informationCOURT OF COMMON PLEAS DRUG DIVERSION PROGRAM
COURT OF COMMON PLEAS DRUG DIVERSION PROGRAM Participant s Handbook New Castle County Drug Diversion Program 500 N. King Street Wilmington, DE 19801 (302) 255-2656 This handbook is designed to answer questions,
More informationExploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications
MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson
More informationTreatment Can Work. SELECT A TOPIC...
Page 1 of 8 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Treatment Can Work Drug Treatment Works Research has revealed a number of
More informationReliability and Validity of Chinese Version of the Addiction Severity Index among Drug Users in the Community *
684 Biomed Environ Sci, 2012; 25(6): 684-689 Original Article Reliability and Validity of Chinese Version of the Addiction Severity Index among Drug Users in the Community * LUO Wei 1,,#, GUO Cai Xia 2,,
More informationPsychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence(review)
Cochrane Database of Systematic Reviews Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence(review) AmatoL,MinozziS,DavoliM,VecchiS
More informationclinic in Israel: disease incidence
15 years of Methadone Maintenance Treatment clinic in Israel: Drug abuse abstinence and minimal infectious disease incidence Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse Treatment & Research Tel-Aviv
More informationHEDIS Initiation and Engagement Quality Measures of Substance Use Disorder Care: Impact of Setting and Health Care Specialty
POPULATION HEALTH MANAGEMENT Volume 12, Number 4, 2009 ª Mary Ann Liebert, Inc. DOI: 10.1089=pop.2008.0028 Original Article HEDIS and Engagement Quality Measures of Substance Use Disorder Care: Impact
More informationCounseling plus Buprenorphine Naloxone Maintenance Therapy for Opioid Dependence
The new england journal of medicine original article Counseling plus Buprenorphine Naloxone Maintenance Therapy for Opioid Dependence David A. Fiellin, M.D., Michael V. Pantalon, Ph.D., Marek C. Chawarski,
More informationThe Value of Engagement in Substance Use Disorder (SUD) Treatment
The Value of Engagement in Substance Use Disorder (SUD) Treatment A Report from Allegheny HealthChoices, Inc. June 2016 Introduction When considering substance use disorder (SUD) treatment, the length
More informationIBR HOME PAGE WHAT S NEW ABOUT IBR RESOURCE COLLECTIONS STAFF PROJECTS NEWSLETTERS PUBLICATIONS PRESENTATIONS MANUALS FORMS OTHER LINKS
Evidence-Based Model Staff Resources Climate Interventio ntionsns T Family & Friends Skills Personal Health Support Alcohol and Offenders: The Alcohol and Addiction and The Alcohol and Addiction and Prevention
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationBehavioral Therapies for Methamphetamine Use
Behavioral Therapies for Methamphetamine Use Will M. Aklin, PhD National Institute on Drug Abuse Division of Therapeutics and Medical Consequences June 27, 2017 1 Behavioral Therapy Development Program
More informationNIH Public Access Author Manuscript Eval Program Plann. Author manuscript; available in PMC 2011 November 1.
NIH Public Access Author Manuscript Published in final edited form as: Eval Program Plann. 2010 November ; 33(4): 403 409. doi:10.1016/j.evalprogplan.2009.11.001. Effects of Receiving Additional Off-Site
More informationVA physicians usually do not detect and treat substance use disorders within the primary care setting
VA physicians usually do not detect and treat substance use disorders within the primary care setting Evaluation report to the VA Mental Health Strategic Healthcare Group VA Central Office, Washington,
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationCHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, : ALCOHOL PROBLEMS
CHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, 1988-1992: ALCOHOL PROBLEMS Shane Darke 1, Margaret Kelahar 1, Wayne Hall 1 & Bruce Flaherty 2 1 National Drug and
More informationUCSF UC San Francisco Previously Published Works
UCSF UC San Francisco Previously Published Works Title Cigarette Smoking and Long-Term Alcohol and Drug Treatment Outcomes: A Telephone Follow-Up at Five Years Permalink https://escholarship.org/uc/item/2t16171p
More informationUniversities of Leeds, Sheffield and York
promoting access to White Rose research papers Universities of Leeds, Sheffield and York http://eprints.whiterose.ac.uk/ This is an author produced version of a paper published in Drug and Alcohol Review.
More informationCSAT Publications -- TAP 25, The Impact of Substance Abuse Treatment on Employment Outcomes Among AFDC Clients in Washington State
CSAT Publications -- TAP 25, The Impact of Substance Abuse Treatment on Employment Outcomes Among AFDC Clients in Washington State Table of Contents The Impact of Substance Abuse Treatment on Employment
More informationThe effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment
The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment By: Gary A. Zarkin, Laura J. Dunlap, Jeremy W. Bray, and Wendee M. Wechsberg Zarkin, G. A.,
More informationClinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version
Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More informationEmergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention Gail D Onofrio, MD, MS 1, Marek C. Chawarski, PhD 1,2, Patrick
More informationTHE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT MARK DUNCAN MD UNIVERSITY OF WASHINGTON SPEAKER DISCLOSURES Any conflicts
More informationPredictors of Outcome in LAAM, Buprenorphine, and Methadone Treatment for Opioid Dependence
Experimental and Clinical Psychopharmacology Copyright 2005 by the American Psychological Association 2005, Vol. 13, No. 4, 293 302 1064-1297/05/$12.00 DOI: 10.1037/1064-1297.13.4.293 Predictors of Outcome
More informationMarijuana remains the most widely used illicit substance in the United
4 A D D I C T I O N S C I E N C E & C L I N I C A L P R A C T I C E D E C E M B E R 2 0 0 7 Marijuana Dependence and Its Treatment The prevalence of marijuana abuse and dependence disorders has been increasing
More informationBlending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings
William R. Miller, Ph.D. The University of New Mexico Have you noticed: that in multisite trials (like CTN) of treatments that are already evidence-based even under highly controlled, supervised, manual
More informationNIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2013 December 15.
NIH Public Access Author Manuscript Published in final edited form as: J Acquir Immune Defic Syndr. 2011 March 1; 56(0 1):. doi:10.1097/qai.0b013e3182097537. Drug Treatment Outcomes among HIV-Infected
More informationSelf-Efficacy. The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland
The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland Bonnie A. Franckowiak, DNP, FNP, CARN-AP Self-Efficacy The belief in one s capabilities
More informationFRN Research Report April 2012: Treatment Outcomes for Women at The Canyon
FRN Research Report April 2012: Treatment Outcomes for Women at The Canyon Background The Canyon Treatment Center treats substance abuse disorders along with mental health issues in Malibu, Calif. The
More informationCharacteristics of reviewed studies: Settings
Characteristics of reviewed studies: Settings Comparisons Included in this Clinical Question Residential versus day treatment ALTERMAN1993 GREENWOOD2001 SCHNEIDER1996 Characteristics of Included Studies
More informationCannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery
Cannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery Lisa Laitman MSEd, LCADC Rutgers, The State University of New Jersey National
More informationTHE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Special Report: Opioid Admissions in Iowa August 2016
Special Report: State of Iowa Opioid Treatment Admissions 21-215 THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Special Report: Opioid Admissions in Iowa 21-215 August 216 With Funds Provided
More informationThe Brief Addiction Monitor (BAM): A Tool to Support Measurement-based Care for People with Substance Use Disorders
: A Tool to Support Measurement-based Care for People with Substance Use Disorders Dominick DePhilippis, PhD Education Coordinator Philadelphia CESATE Eric J. Hawkins, PhD Associate Director Seattle CESATE
More informationCrits-Christoph et al. Substance Abuse Treatment, Prevention, and Policy 2014, 9:3
Crits-Christoph et al. Substance Abuse Treatment, Prevention, and Policy 2014, 9:3 RESEARCH Open Access Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse
More informationDrug Misuse Research Division
Drug Misuse Research Division contents Occasional Paper No. 1/ 2002 - Background - NDTRS methodology - Treatment as an indicator of drug misuse - Treatment provision - Extent of the problem - Socio-demographic
More informationBefore the advent of research on treatments derived
Reviews and Overviews Behavioral Therapies for Drug Abuse Kathleen M. Carroll, Ph.D. Lisa S. Onken, Ph.D. The past three decades have been marked by tremendous progress in behavioral therapies for drug
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationDifferences in Prevalence of Prescription Opiate Misuse Among Rural and Urban Probationers
The American Journal of Drug and Alcohol Abuse, 33: 309 317, 2007 Copyright Q Informa Healthcare ISSN: 0095-2990 print/1097-9891 online DOI: 10.1080/00952990601175078 Differences in Prevalence of Prescription
More informationEast-West Research. Samples of Journal Abstracts
East-West Research Samples of Journal Abstracts # 1 Sapir-Weise, R., Berglund, M., Frank, A., and Kristenson, H. (1999) Acupuncture in Alcoholism Treatment: A Randomized Out-Patient Study. Alcohol & Alcoholism
More informationPersonality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans with comorbid axis I disorders
Washington University School of Medicine Digital Commons@Becker Posters 2005: Alcoholism and Comorbidity 2005 Personality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans
More informationNovelty seeking as a predictor of treatment retention for heroin dependent cocaine users
Drug and Alcohol Dependence 61 (2001) 287 295 www.elsevier.com/locate/drugalcdep Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users Todd C. Helmus *, Karen K. Downey,
More information